Chiara Ghiron

Title: Chiara Ghiron: Innovator in Calcium Receptor Modulation

Introduction

Chiara Ghiron is a prominent inventor based in Wootton, GB. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of calcium receptor modulating agents. With a total of 7 patents to her name, Ghiron is recognized for her innovative approaches to treating diseases related to calcium sensing receptors.

Latest Patents

Ghiron's latest patents include groundbreaking work on calcium receptor modulating agents. The first patent relates to compounds represented in Formula I, which are pharmaceutical compositions aimed at treating diseases or disorders associated with the function of the calcium sensing receptor. This invention also encompasses processes for making such compounds and intermediates useful in these processes. The second patent focuses on novel calcimimetic compounds and their pharmaceutical compositions. It outlines methods for treating diseases or disorders related to the calcium sensing receptor using the compounds represented in Formula I.

Career Highlights

Chiara Ghiron is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to further her research and development efforts in the field of calcium receptor modulation. Ghiron's innovative contributions have positioned her as a key figure in her area of expertise.

Collaborations

Some of her notable coworkers include Michael G Kelly and Thomas Stephen Coulter. Their collaborative efforts have contributed to the advancement of research in calcium receptor modulation.

Conclusion

Chiara Ghiron is a trailblazer in the field of pharmaceutical innovation, particularly in calcium receptor modulation. Her patents and work at Amgen Inc. reflect her commitment to advancing medical science and improving treatment options for patients.